Cargando…
Mistletoe lectin inhibits growth of Myc‐amplified small‐cell lung cancer
BACKGROUND: Small‐cell lung cancer (SCLC) is the deadliest form of lung cancer but lacks targeted therapies. METHODS: We studied the effect of the natural product mistletoe lectin (ML) in pre‐clinical models of SCLC, focusing on cell lines with amplification of the myc family oncogenes C‐myc and N‐m...
Autores principales: | Shatat, Mohammad A., Gauthier, Betsy, Yoon, Suzy, Yuan, Eric, Yang, Peiying, Narla, Goutham, Dowlati, Afshin, Lee, Richard T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134353/ https://www.ncbi.nlm.nih.gov/pubmed/36562288 http://dx.doi.org/10.1002/cam4.5558 |
Ejemplares similares
-
Mistletoe extract Fraxini inhibits the proliferation of liver cancer by down-regulating c-Myc expression
por: Yang, Peiying, et al.
Publicado: (2019) -
Mistletoe Extract Viscum Fraxini-2 for Treatment of Advanced Hepatocellular Carcinoma: A Case Series
por: Lee, Richard T., et al.
Publicado: (2021) -
Impact of Mistletoe Triterpene Acids on the Uptake of Mistletoe Lectin by Cultured Tumor Cells
por: Mulsow, Katharina, et al.
Publicado: (2016) -
Difficulties and Perspectives of Immunomodulatory Therapy with Mistletoe Lectins and Standardized Mistletoe Extracts in Evidence-Based Medicine
por: Hajtó, Tibor, et al.
Publicado: (2011) -
Characterization of Sialic Acid Affinity of the Binding Domain of Mistletoe Lectin Isoform One
por: Mohammed, Soran, et al.
Publicado: (2021)